Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Hemorrhoids Market Growth From $3.11 Billion In 2026 To $3.96 Billion By 2030 At A CAGR Of 6.2%
The hemorrhoids market has demonstrated substantial growth in recent years. It is projected to expand from $2.93 billion in 2025 to $3.11 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.4%. This past growth is attributable to several factors, including the increasing prevalence of sedentary lifestyles, a rise in chronic constipation incidents, heightened awareness of anorectal disorders, the expansion of outpatient treatment facilities, and the availability of diverse treatment options.
The hemorrhoids market is anticipated to experience substantial expansion over the coming years. By 2030, this market is projected to reach $3.96 billion, demonstrating a compound annual growth rate (CAGR) of 6.2%. Factors contributing to this growth during the outlook period include a growing elderly demographic, an elevated emphasis on prompt diagnosis and therapeutic interventions, an increasing desire for less invasive surgical options, the broader adoption of teleconsultation for anorectal health, and the wider accessibility of cutting-edge treatment methods. Key trends anticipated during the forecast encompass a greater embrace of minimally invasive approaches for hemorrhoid management, a heightened consumer demand for non-prescription drugs, the increasing application of non-surgical techniques, the development of home-based care solutions, and a stronger emphasis on patient well-being and recuperation.
Get A Free Sample Report With In-Depth Market Insights:
Hemorrhoids Market Demand Drivers: What’s Powering Industry Growth?
Future expansion of the hemorrhoids market is anticipated to be spurred by increasing healthcare spending. Healthcare expenditure encompasses all financial investments made by individuals, organizations, or governments towards the prevention, treatment, and management of various health conditions. This increase in healthcare expenditure stems from advancements in medical technology, as newer diagnostic instruments, therapies, and innovative treatments frequently incur greater expenses, thereby raising overall healthcare costs. Elevated healthcare spending enhances the availability of treatment, preventive measures, medications, and sophisticated procedures, which in turn improves the management and results for hemorrhoids. For example, as reported in December 2024 by the Centers for Medicare & Medicaid Services, a US-based agency overseeing Medicare and Medicaid programs, U.S. health care expenditures saw a 7.5% rise in 2023, reaching $4.9 trillion, or approximately $14,570 per person. Consequently, the escalating healthcare expenditure is a key factor propelling the growth of the hemorrhoids market.
Hemorrhoids Market Segment Breakdown: Which Categories Lead On Revenue?
The hemorrhoids market covered in this report is segmented –
1) By Type: Internal Hemorrhoids, External Hemorrhoids, Mixed Hemorrhoids
2) By Treatment Type: Medications, Procedures And Surgical Treatments
3) By End User: Hospitals, Clinics, Ambulatory Surgery Centers (ASCs), Homecare
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Internal Hemorrhoids: Grade I, Grade II, Grade III, Grade IV
2) By External Hemorrhoids: Thrombosed External Hemorrhoids, Non-Thrombosed External Hemorrhoids
3) By Mixed Hemorrhoids: Combined Internal And External Hemorrhoids, Prolapsed Hemorrhoids
Hemorrhoids Market Innovation Trends Shaping Future Development
Major companies operating in the hemorrhoid market are developing innovative surgical products, such as minimally invasive hemorrhoid treatments, to enhance patient comfort, reduce recovery time, and improve clinical outcomes. A minimally invasive hemorrhoid treatment involves advanced medical procedures that reduce tissue damage, pain, and recovery time compared to traditional hemorrhoidectomy methods. For instance, in December 2023, Medical Fintech Innovations B.V., a Netherlands-based technology company, introduced the HemWell GEN 2. This next-generation device features the innovative Hemwellectomy procedure, a minimally invasive electrosurgical solution for hemorrhoids. This advanced technique is designed to offer patients a less painful alternative to traditional hemorrhoidectomy procedures, promoting faster recovery and enabling a quicker return to daily activities.
Hemorrhoids Market Leading Players And Competitive Positioning
Major companies operating in the hemorrhoids market are Johnson & Johnson, Bayer AG, Abbott Laboratories, Medtronic Plc, Takeda Pharmaceutical Company, Boston Scientific Corporation, Church & Dwight Co. Inc., Dr. Reddy’s Laboratories Ltd, Glenmark Pharmaceuticals, B. Braun Melsungen AG, Sebela Pharmaceuticals, Citius Pharmaceuticals, AMATO PHARMACEUTICAL PRODUCTS LTD, Surkon Medical Co. Ltd., Privi Medical, CONMED Corporation, Integra LifeSciences Corporation, Takeda Consumer Healthcare, Fresenius Kabi, Sanofi
View The Full Hemorrhoids Market Report:
Hemorrhoids Market Global Footprint: Which Region Leads The Market?
North America was the largest region in the hemorrhoids market in 2025. The regions covered in the hemorrhoids market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model









